Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Pathogene
1.2.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth Rate by Pathogene: 2018 VS 2022 VS 2033
1.2.2 Mycoplasma Pneumoniae
1.2.3 Streptococcus Pneumoniae
1.2.4 Haemophilus Influenzae
1.2.5 Moraxella Catarrhalis
1.2.6 Chlamydia Pneumoniae
1.2.7 Klebsiella Pneumoniae
1.2.8 Staphylococcus Aureus
1.2.9 Others
1.3 Market by Application
1.3.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Infant (<1 year old)
1.3.3 Children and Adolescents (1-25 years old)
1.3.4 Adult (25-65 years old)
1.3.5 Senior citizens (over 65 years old)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Perspective (2018-2033)
2.2 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Growth Trends by Region
2.2.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Historic Market Size by Region (2018-2023)
2.2.3 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Region (2024-2033)
2.3 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Dynamics
2.3.1 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Industry Trends
2.3.2 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Drivers
2.3.3 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Challenges
2.3.4 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Players by Revenue
3.1.1 Global Top LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Players by Revenue (2018-2023)
3.1.2 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue Market Share by Players (2018-2023)
3.2 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue
3.4 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Concentration Ratio
3.4.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue in 2022
3.5 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Key Players Head office and Area Served
3.6 Key Players LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product Solution and Service
3.7 Date of Enter into LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Breakdown Data by Type
4.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Historic Market Size by Type (2018-2023)
4.2 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Type (2024-2033)
5 LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Breakdown Data by Application
5.1 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Historic Market Size by Application (2018-2023)
5.2 Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2018-2033)
6.2 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2018-2023)
6.4 North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2018-2033)
7.2 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2018-2023)
7.4 Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2018-2033)
8.2 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Region (2018-2023)
8.4 Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2018-2033)
9.2 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2018-2023)
9.4 Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (2018-2033)
10.2 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2018-2023)
10.4 Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CapitalBio
11.1.1 CapitalBio Company Detail
11.1.2 CapitalBio Business Overview
11.1.3 CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.1.4 CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
11.1.5 CapitalBio Recent Development
11.2 BGI
11.2.1 BGI Company Detail
11.2.2 BGI Business Overview
11.2.3 BGI LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.2.4 BGI Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
11.2.5 BGI Recent Development
11.3 Eiken Chemical
11.3.1 Eiken Chemical Company Detail
11.3.2 Eiken Chemical Business Overview
11.3.3 Eiken Chemical LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.3.4 Eiken Chemical Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
11.3.5 Eiken Chemical Recent Development
11.4 Deaou Biotechnology
11.4.1 Deaou Biotechnology Company Detail
11.4.2 Deaou Biotechnology Business Overview
11.4.3 Deaou Biotechnology LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.4.4 Deaou Biotechnology Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
11.4.5 Deaou Biotechnology Recent Development
11.5 Singuway
11.5.1 Singuway Company Detail
11.5.2 Singuway Business Overview
11.5.3 Singuway LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.5.4 Singuway Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
11.5.5 Singuway Recent Development
11.6 New England Biolabs
11.6.1 New England Biolabs Company Detail
11.6.2 New England Biolabs Business Overview
11.6.3 New England Biolabs LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.6.4 New England Biolabs Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
11.6.5 New England Biolabs Recent Development
11.7 Lucigen Corporation
11.7.1 Lucigen Corporation Company Detail
11.7.2 Lucigen Corporation Business Overview
11.7.3 Lucigen Corporation LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.7.4 Lucigen Corporation Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
11.7.5 Lucigen Corporation Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.8.4 Merck Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
11.8.5 Merck Recent Development
11.9 Mast Group
11.9.1 Mast Group Company Detail
11.9.2 Mast Group Business Overview
11.9.3 Mast Group LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.9.4 Mast Group Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
11.9.5 Mast Group Recent Development
11.10 OptiGene
11.10.1 OptiGene Company Detail
11.10.2 OptiGene Business Overview
11.10.3 OptiGene LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.10.4 OptiGene Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
11.10.5 OptiGene Recent Development
11.11 CapitalBio
11.11.1 CapitalBio Company Detail
11.11.2 CapitalBio Business Overview
11.11.3 CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.11.4 CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
11.11.5 CapitalBio Recent Development
11.12 Weifang Kanghua Biotech Co.,Ltd
11.12.1 Weifang Kanghua Biotech Co.,Ltd Company Detail
11.12.2 Weifang Kanghua Biotech Co.,Ltd Business Overview
11.12.3 Weifang Kanghua Biotech Co.,Ltd LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.12.4 Weifang Kanghua Biotech Co.,Ltd Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
11.12.5 Weifang Kanghua Biotech Co.,Ltd Recent Development
11.13 CapitalBio
11.13.1 CapitalBio Company Detail
11.13.2 CapitalBio Business Overview
11.13.3 CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.13.4 CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
11.13.5 CapitalBio Recent Development
11.14 BGI
11.14.1 BGI Company Detail
11.14.2 BGI Business Overview
11.14.3 BGI LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Introduction
11.14.4 BGI Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
11.14.5 BGI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Mycoplasma Pneumoniae
Table 3. Key Players of Streptococcus Pneumoniae
Table 4. Key Players of Haemophilus Influenzae
Table 5. Key Players of Moraxella Catarrhalis
Table 6. Key Players of Chlamydia Pneumoniae
Table 7. Key Players of Klebsiella Pneumoniae
Table 8. Key Players of Staphylococcus Aureus
Table 9. Key Players of Others
Table 10. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 12. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Region (2018-2023) & (US$ Million)
Table 13. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Region (2018-2023)
Table 14. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 15. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Region (2024-2033)
Table 16. LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Trends
Table 17. LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Drivers
Table 18. LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Challenges
Table 19. LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Restraints
Table 20. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue by Players (2018-2023) & (US$ Million)
Table 21. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Players (2018-2023)
Table 22. Global Top LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease as of 2022)
Table 23. Ranking of Global Top LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Companies by Revenue (US$ Million) in 2022
Table 24. Global 5 Largest Players Market Share by LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue (CR5 and HHI) & (2018-2023)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product Solution and Service
Table 27. Date of Enter into LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Type (2018-2023) & (US$ Million)
Table 30. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue Market Share by Type (2018-2023)
Table 31. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 32. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue Market Share by Type (2024-2033)
Table 33. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Application (2018-2023) & (US$ Million)
Table 34. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue Market Share by Application (2018-2023)
Table 35. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 36. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue Market Share by Application (2024-2033)
Table 37. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2018-2023) & (US$ Million)
Table 42. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2024-2033) & (US$ Million)
Table 43. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 44. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Region (2018-2023) & (US$ Million)
Table 45. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Region (2024-2033) & (US$ Million)
Table 46. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2018-2023) & (US$ Million)
Table 48. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2024-2033) & (US$ Million)
Table 49. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 50. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2018-2023) & (US$ Million)
Table 51. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size by Country (2024-2033) & (US$ Million)
Table 52. CapitalBio Company Detail
Table 53. CapitalBio Business Overview
Table 54. CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 55. CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023) & (US$ Million)
Table 56. CapitalBio Recent Development
Table 57. BGI Company Detail
Table 58. BGI Business Overview
Table 59. BGI LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 60. BGI Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023) & (US$ Million)
Table 61. BGI Recent Development
Table 62. Eiken Chemical Company Detail
Table 63. Eiken Chemical Business Overview
Table 64. Eiken Chemical LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 65. Eiken Chemical Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023) & (US$ Million)
Table 66. Eiken Chemical Recent Development
Table 67. Deaou Biotechnology Company Detail
Table 68. Deaou Biotechnology Business Overview
Table 69. Deaou Biotechnology LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 70. Deaou Biotechnology Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023) & (US$ Million)
Table 71. Deaou Biotechnology Recent Development
Table 72. Singuway Company Detail
Table 73. Singuway Business Overview
Table 74. Singuway LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 75. Singuway Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023) & (US$ Million)
Table 76. Singuway Recent Development
Table 77. New England Biolabs Company Detail
Table 78. New England Biolabs Business Overview
Table 79. New England Biolabs LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 80. New England Biolabs Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023) & (US$ Million)
Table 81. New England Biolabs Recent Development
Table 82. Lucigen Corporation Company Detail
Table 83. Lucigen Corporation Business Overview
Table 84. Lucigen Corporation LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 85. Lucigen Corporation Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023) & (US$ Million)
Table 86. Lucigen Corporation Recent Development
Table 87. Merck Company Detail
Table 88. Merck Business Overview
Table 89. Merck LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 90. Merck Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023) & (US$ Million)
Table 91. Merck Recent Development
Table 92. Mast Group Company Detail
Table 93. Mast Group Business Overview
Table 94. Mast Group LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 95. Mast Group Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023) & (US$ Million)
Table 96. Mast Group Recent Development
Table 97. OptiGene Company Detail
Table 98. OptiGene Business Overview
Table 99. OptiGene LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 100. OptiGene Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023) & (US$ Million)
Table 101. OptiGene Recent Development
Table 102. CapitalBio Company Detail
Table 103. CapitalBio Business Overview
Table 104. CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 105. CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023) & (US$ Million)
Table 106. CapitalBio Recent Development
Table 107. Weifang Kanghua Biotech Co.,Ltd Company Detail
Table 108. Weifang Kanghua Biotech Co.,Ltd Business Overview
Table 109. Weifang Kanghua Biotech Co.,Ltd LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 110. Weifang Kanghua Biotech Co.,Ltd Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023) & (US$ Million)
Table 111. Weifang Kanghua Biotech Co.,Ltd Recent Development
Table 112. CapitalBio Company Detail
Table 113. CapitalBio Business Overview
Table 114. CapitalBio LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 115. CapitalBio Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023) & (US$ Million)
Table 116. CapitalBio Recent Development
Table 117. BGI Company Detail
Table 118. BGI Business Overview
Table 119. BGI LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Product
Table 120. BGI Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023) & (US$ Million)
Table 121. BGI Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Type: 2022 VS 2033
Figure 3. Mycoplasma Pneumoniae Features
Figure 4. Streptococcus Pneumoniae Features
Figure 5. Haemophilus Influenzae Features
Figure 6. Moraxella Catarrhalis Features
Figure 7. Chlamydia Pneumoniae Features
Figure 8. Klebsiella Pneumoniae Features
Figure 9. Staphylococcus Aureus Features
Figure 10. Others Features
Figure 11. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 12. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Application: 2022 VS 2033
Figure 13. Infant (<1 year old) Case Studies
Figure 14. Children and Adolescents (1-25 years old) Case Studies
Figure 15. Adult (25-65 years old) Case Studies
Figure 16. Senior citizens (over 65 years old) Case Studies
Figure 17. LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Report Years Considered
Figure 18. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 19. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 20. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Region: 2022 VS 2033
Figure 21. Global LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Players in 2022
Figure 22. Global Top LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Revenue in 2022
Figure 24. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. North America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Country (2018-2033)
Figure 26. United States LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Canada LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Europe LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Country (2018-2033)
Figure 30. Germany LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Asia-Pacific LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Region (2018-2033)
Figure 38. China LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Japan LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. South Korea LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Southeast Asia LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. India LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Australia LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Latin America LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Country (2018-2033)
Figure 46. Mexico LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Brazil LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East & Africa LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Share by Country (2018-2033)
Figure 50. Turkey LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Saudi Arabia LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. CapitalBio Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
Figure 53. BGI Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
Figure 54. Eiken Chemical Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
Figure 55. Deaou Biotechnology Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
Figure 56. Singuway Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
Figure 57. New England Biolabs Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
Figure 58. Lucigen Corporation Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
Figure 59. Merck Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
Figure 60. Mast Group Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
Figure 61. OptiGene Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
Figure 62. CapitalBio Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
Figure 63. Weifang Kanghua Biotech Co.,Ltd Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
Figure 64. CapitalBio Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
Figure 65. BGI Revenue Growth Rate in LAMP (Loop-mediated Isothermal Amplification) Technology for Respiratory Disease Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed